Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,243 INR | +1.76% |
|
-0.91% | +14.69% |
06-05 | Hindalco-owned Novelis delays US IPO; shares slide | RE |
05-27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.69% | 8.58B | |
+52.93% | 803B | |
+41.25% | 631B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.72% | 243B | |
+2.17% | 228B | |
+10.27% | 217B | |
+6.24% | 164B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- US FDA Clears Aurobindo Pharma Arm's Manufacturing Unit in Telangana, India